Kiunnei N. Shadrinova

Kiunnei N. Shadrinova

Auto-generated profile, based on publicly available information

Kiunnei N. Shadrinova

State Research Center of Virology and Biotechnology VECTOR

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
Verified
Journal Article
Open access
PDF file
NBNikita D. Boldyrev
Nikita D. Boldyrev
APAnastasia S. Panova
Anastasia S. Panova
NKNatalia P. Kolosova
Natalia P. Kolosova
ADAlexey Danilenko
Alexey Danilenko
KSKiunnei N. Shadrinova
Kiunnei N. Shadrinova
ARAlexander B Ryzhikov
Alexander B Ryzhikov
Introduction: Influenza is a highly contagious disease which can cause severe complications and even death, particularly in high-risk populations. Continuous monitoring and careful testing of seasonal influenza viruses, especially for severe cases, is necessary to develop and optimize prevention and treatment. Objective: To establish genetic and antigenic characteristics of influenza viruses detected in lethal cases in the Russian Federation in the 2023–2024 respiratory virus season. Materials and methods: From September 29, 2023 to June 1, 2024, 859 specimens from influenza cases (nasopharyngeal swabs) and 101 autopsy specimens of trachea, bronchi, and lungs from lethal cases of the disease from 57 regions of the Russian Federation were analyzed by PCR. For those with a sufficient amount of genetic material, whole-genome sequencing was performed using the Illumina MiSeq platform. Results: The 2023–2024 influenza season in the Russian Federation was characterized by the dominance of A/H3N2 viruses of subclade 2a.3a.1. Influenza A/H1N1pdm09 and influenza type B viruses were detected to a lesser extent in that period. Additional diversification of A/H3N2 viruses was observed during the season with accumulation of amino acid substitutions in the hemagglutinin antigenic sites. Most lethal cases were among those at high risk and unvaccinated. No mutations associated with increased pathogenicity and virulence were identified in A/H3N2 viruses from lethal cases. No molecular markers of drug resistance to neuraminidase inhibitors and baloxavir marboxil were identified in all viruses tested in the 2023–2024 season. Conclusion: Influenza A/H3N2 viruses from the lethal cases of the diseases tested at the State Research Center for Virology and Biotechnology “Vector” in the 2023–2024 respiratory virus season were similar to those detected in recovered patients. The isolated viruses were genetically and antigenically similar to the vaccine strain and had no markers of increased pathogenicity or drug resistance.

30 April 2025 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
SSSvetlana Svyatchenko
Svetlana Svyatchenko
NBNikita D. Boldyrev
Nikita D. Boldyrev
APAnastasia S. Panova
Anastasia S. Panova
NKNatalia P. Kolosova
Natalia P. Kolosova
KSKiunnei N. Shadrinova
Kiunnei N. Shadrinova
ARAlexander B Ryzhikov
Alexander B Ryzhikov

30 March 2026 in Problems of Particularly Dangerous Infections
Verified
Journal Article
Closed access
AEA. I. Enikeeva
A. I. Enikeeva
APA. S. Panova
A. S. Panova
NVN. N. Vasiltsova
N. N. Vasiltsova
ADAlexey Danilenko
Alexey Danilenko
KSK. N. Shadrinova
K. N. Shadrinova
VMVasily Marchenko
Vasily Marchenko
In 2025, high epizootic activity of highly pathogenic avian influenza virus (HPAIV) persisted globally, as evidenced by more than 7,000 outbreaks reported in poultry and wild birds across 75 countries, resulting in mortality or culling of birds exceeding 98 million specimens. The majority of outbreaks worldwide were associated with HPAIV A(H5N1) clade 2.3.4.4b, which has remained the predominant lineage in global circulation since 2021. In addition to the dominant A(H5N1) clade 2.3.4.4b subtype, circulation of other highly pathogenic subtypes was observed, including A(H5N5), A(H5N2), A(H5N8), and A(H5N9), as well as A(H7), indicating ongoing evolution of avian influenza viruses in natural and anthropogenic ecosystems. In the United States and several other countries, HPAIV A(H5N1) caused numerous infections in wild and domestic mammals as well as in humans. In 2025, the world’s first human case of A(H5N5) influenza was documented in the United States. A total of 74 zoonotic HPAIV human infections were reported globally in 2025, including 32 cases caused by A(H5) viruses of various clades (2.3.4.4b, 2.3.2.1e, 2.3.2.1a), reflecting a continuing increase in interspecies transmission that poses a potential public health threat. In the Russian Federation, high epizootic activity of HPAIV persisted throughout 2025, with outbreaks caused by A(H5N1) clade 2.3.4.4b viruses reported in both wild and domestic birds. Notably, in the Russian Far East, circulation of an A(H5N1) virus carrying mammalian-adaptive mutations associated with increased virulence in mammals was detected. Additionally, amino acid substitutions in antigenic sites were identified in several A(H5N1) isolates. Despite ongoing virus evolution, no substantial alterations in the antigenic properties of HPAIV A(H5N1) strains circulating in the Russian Federation have been observed to date.

28 March 2025 in Problems of Particularly Dangerous Infections
Verified
Journal Article
Open access
PDF file
NVN. N. Vasiltsova
N. N. Vasiltsova
APA. S. Panova
A. S. Panova
VPV. N. Petrov
V. N. Petrov
ADAlexey Danilenko
Alexey Danilenko
KSK. N. Shadrinova
K. N. Shadrinova
VMVasily Marchenko
Vasily Marchenko
The aim of the work was to analyze the circulation of the most epidemiologically significant variants of the avian influenza virus in the world and across Russia in 2024. The global situation on highly pathogenic avian influenza remained tense in 2024. The disease affected 68 countries, resulting in the death or culling of about 19 million poultry. In addition, there was a large number of influenza A(H5N1) virus detections in wild and domestic mammals, predominantly in the United States. Those included outbreaks on dairy farms that affected herds throughout the year, encompassing more than 900 dairy farms in 16 states by the year’s end and causing infection of 40 farm workers in four states. The A(H5N1) viruses detected in farm workers contained mammalian adaptation mutations. In total, more than 100 human infections with zoonotic variants of influenza virus were reported in 2024, with influenza A(H5N1) virus detected in 81 cases. Apart from outbreaks of A(H5N1), other influenza virus variants, such as A(H5N6), A(H5N8), A(H5N5), A(H5N2), were circulating worldwide. Outbreaks among poultry caused by different subtypes of influenza A(H7) virus were also reported in a number of countries. In Russia, the situation on highly pathogenic influenza virus in 2024 was less tense. All detected influenza A(H5N1) viruses belonged to clade 2.3.4.4b and were genetically similar to the vaccine strains recommended by WHO. Isolated strains were antigenically similar to a reference strain A/goose/Tyumen/359- 13/2021(H5N1), which had HA1 sequence identical to the vaccine strain A/Astrakhan/3212/2020(H5N8). In addition, an influenza A(H9N2) virus was isolated in 2024. The study of this strain showed that it belongs to the clade Y439 and does not contain mutations associated with increased pathogenicity and drug resistance.

25 December 2025 in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
Verified
Journal Article
Closed access
APAnastasia S. Panova
Anastasia S. Panova
NKNatalia P. Kolosova
Natalia P. Kolosova
ADAlexey Danilenko
Alexey Danilenko
NBNikita D. Boldyrev
Nikita D. Boldyrev
KSKiunnei N. Shadrinova
Kiunnei N. Shadrinova
VMVasily Marchenko
Vasily Marchenko
Introduction: Seasonal influenza circulates in an epidemic pattern, with periodic shifts in the dominant subtype driven by antigenic drift and population immunity. Mutations in surface proteins – particularly within the hemagglutinin receptor-binding site (RBS) – enable the virus to evade host immune responses. Among these, the D222G/N substitution has been associated with increased virulence of A(H1N1)pdm09 viruses. Objective: Genetic characterization of viruses detected in influenza cases in the Russian Federation in the 2024–2025 epidemic season. Materials and methods: From September 10, 2024, to June 19, 2025, 1,931 specimens from patients with influenza, including 240 autopsy samples, were tested by RT-PCR. For 420 samples with sufficient genetic material, influenza virus genome sequences were obtained using NGS. Results: During the 2024–2025 flu season, A(H1N1)pdm09 viruses predominated in the Russian Federation. Influenza B/Victoria lineage viruses were less frequent while influenza A (H3N2) cases were sporadic. Most fatal cases occurred in individuals belonging to risk groups, with a notably low vaccination coverage among them. Among fatal A(H1N1)pdm09 cases, the HA-D222N mutation – a marker of enhanced virulence – was detected in the major viral variant in 19.0 % of sequenced samples. Additionally, D222G/N mutations were identified in minor variants in 10.1 % of fatal cases. Notably, the D222N mutation in the major variant was also found in one recovered A(H1N1)pdm09 case (0.5 %). Resistance markers to antiviral drugs – oseltamivir (1.9 %) and baloxavir marboxil (0.4 %) were detected in 6 of all sequenced A(H1N1)pdm09 viruses (2.3 %). Conclusion: The detection of HA-D222G/N mutations associated with increased virulence and fatality from A(H1N1)pdm09 viruses underscores the importance of vaccination as a key preventive measure, particularly for population groups at risk, and timely treatment for influenza.